70 / 74
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 6, November/December 2018
402
AFRICA
6.
Sliwa K, Libhaber E, Elliott C, Momberg Z, Osman A, Zuhlke L,
et al
.
Spectrum of cardiac disease in maternity in a low-resource cohort in
South Africa.
Heart
2014;
100
: 1967–1974.
7.
Diao M, Kane A, Ndiaye MB, Mbaye A, Bodian M, Dia MM,
et al
.
Pregnancy in women with heart disease in sub-Saharan Africa.
Arch
Cardiovasc Dis
2011;
104
: 370–374.
8.
Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P,
Cupido B,
et al
. Characteristics, complications, and gaps in evidence-
based interventions in rheumatic heart disease: the Global Rheumatic
Heart Disease Registry (the REMEDY study).
Eur Heart J
2015;
36
:
1115–1122.
9.
Walker KG, Human DG, De Moor MM, Sprenger KJ. The problem of
compliance in rheumatic fever.
S Afr Med J
1987;
72
: 781–783.
10. WHO Technical Report Series 923. Rheumatic fever and rheumatic
heart disease. Geneva, 2005 29 October – 1 November 2001.
11. Mocumbi AO, Sliwa K. Women’s cardiovascular health in Africa.
Heart
2012;
98
: 450–455.
12. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden
of group A streptococcal diseases.
Lancet Infect Dis
2005;
5
: 685–694.
13. Guengant J, May JF. African demography.
Glob J Emerg Market Econ
2013;
12
: 215–267.
14. AFRI-DEV Info. Maternal dealth risk. http://wwwafri-devinfo/ 2016;
Accessed 8 November 2017.
15. AFRI-DEV Info. Multisectoral information, data, research and
evidence – for health, population, human and social development http://
wwwafri-devinfo/ 2016; Accessed 8 November 2017.
16. United Nations. Contraceptive prevalence: Unicef analysis based
on United Nations, Department of Economic and Social Affairs,
Population Division, model-based estimates and projections of family
planning indicators. http://wwwtakepartcom/article/2014/11/07/africa-
contraception-child-population 2014.
17. Mucumbitsi J, Bulwer B, Mutesa L, Ndahindwa V, Semakula M,
Rusingiza E,
et al
. Prevalence of rheumatic valvular heart disease in
Rwandan school children: echocardiographic evaluation using the
World Heart Federation criteria.
Cardiovasc J Afr
2017;
28
: 1–8.
18. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D,
et
al
. Prevalence of rheumatic heart disease detected by echocardiographic
screening.
New Engl J Med
2007;
357
: 470–476.
19. Gemechu T, Mahmoud H, Parry EH, Phillips DI, Yacoub MH.
Community-based prevalence study of rheumatic heart disease in rural
Ethiopia.
Eur J Prevent Cardiol
2017;
24
: 717–723.
20. Yadeta D, Hailu A, Haileamlak A, Gedlu E, Guteta S, Tefera E,
et
al
. Prevalence of rheumatic heart disease among school children in
Ethiopia: A multisite echocardiography-based screening.
Int J Cardiol
2016;
221
: 260–263.
21. Zuhlke LJ, Engel ME, Watkins D, Mayosi BM. Incidence, prevalence
and outcome of rheumatic heart disease in South Africa: a systematic
review of contemporary studies.
Int J Cardiol
2015;
199
: 375–383.
22. Rossi E, Felici AR, Banteyrga L. Subclinical rheumatic heart disease
in an Eritrean high-school population, detected by echocardiography.
J
Heart Valve Dis
2014;
23
: 235–239.
23. Sadoh WE, Omuemu VO, Israel-aina YT. Prevalence of rheumatic heart
disease among primary school pupils in mid-western Nigeria.
East Afr
Med J
2013;
90
: 28–32.
24. Russell EA, Tran L, Baker RA, Bennetts JS, Brown A, Reid CM,
et al
.
A review of outcome following valve surgery for rheumatic heart disease
in Australia.
BMC Cardiovasc Disord
2015;
15
: 103.
25. Sliwa K, Johnson MR, Zilla P, Roos-Hesselink JW. Management of
valvular disease in pregnancy: a global perspective.
Eur Heart J
2015;
36
: 1078–1089.
26. Dennis A. Valvular heart disease in pregnancy.
Int J Obstet Anesth
2016;
25
: 4–8.
27. Ntusi NA, Samuels P, Moosa S, Mocumbi AO. Diagnosing cardiac
disease during pregnancy: imaging modalities.
Cardiovasc J Afr
2016;
27
: 95–103.
28. Michaelson-Cohen R, Elstein D, Ioscovich A, Armon S, Schimmel MS,
Butnaru A,
et al
. Severe heart disease complicating pregnancy does not
preclude a favourable pregnancy outcome: 15 years’ experience in a
single centre.
J Obstet Gynaecol
2011;
31
: 597–602.
29. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman
ST, Taubert KA. Prevention of rheumatic fever and diagnosis and treat-
ment of acute Streptococcal pharyngitis: a scientific statement from
the American Heart Association Rheumatic Fever, Endocarditis, and
Kawasaki Disease Committee of the Council on Cardiovascular Disease
in the Young, the Interdisciplinary Council on Functional Genomics
and Translational Biology, and the Interdisciplinary Council on Quality
of Care and Outcomes Research: endorsed by the American Academy
of Pediatrics.
Circulation
2009;
119
: 1541–1551.
30. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheu-
matic fever.
Cochrane Syst Rev
2002: CD002227.
31. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical
application of transvenous mitral commissurotomy by a new balloon
catheter.
J Thorac Cardiovasc Surg
1984;
87
: 394–402.
32. Ben Farhat M, Gamra H, Betbout F, Maatouk F, Jarrar M, Addad F,
et al.
Percutaneous balloon mitral commissurotomy during pregnancy.
Heart
1997;
77
: 564–567.
33. Reyes VP, Raju BS, Wynne J, Stephenson LW, Raju R, Fromm BS,
et al
. Percutaneous balloon valvuloplasty compared with open surgi-
cal commissurotomy for mitral stenosis.
New Engl J Med
1994;
331
:
961–967.
34. Vahanian A, Lung B, Pierard LA, Dion R, Pepper J. Valvular vascular
diseases. In: Camm A, Luscher TF, Serruys P, eds.
The ESC Textbook of
Cardiovascular Medicine
. Oxford: Blackwell; 2006: 625–670.
35. Karthikeyan G, Zuhlke L, Engel M, Rangarajan S, Yusuf S, Teo K,
Mayosi BM. Rationale and design of a Global Rheumatic Heart
Disease Registry: the REMEDY study.
Am Heart J
2012;
163
: 535–540
e1.
36. Marijon E, Iung B, Mocumbi AO, Kamblock J, Thanh CV, Gamra H,
et al
. What are the differences in presentation of candidates for percu-
taneous mitral commissurotomy across the world and do they influence
the results of the procedure?
Arch Cardiovasc Dis
2008;
101
: 611–617.
37. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF.
Percutaneous balloon dilatation of the mitral valve: an analysis of
echocardiographic variables related to outcome and the mechanism of
dilatation.
Br Heart J
1988;
60
: 299–308.
38. Kumar AS, Rao PN, Dharmapuram AK, Chander H, Trehan H.
Pulmonary autograft aortic valve replacement. Early experience with
the Ross procedure.
Texas Heart Inst J
1995;
22
: 177–179.
39. Herrey A, Nelson-Piercy C. Cardiovascular disease in pregnancy.
Medicine
2010;
10
: 555–560.
40. Birincioglu CL, Unal EU, Celik IH, Ozen A, Tak S, Aksoyek A,
et
al
. Surgery for rheumatic valve disease in pregnancy: what about the
newborn?
Heart Lung Circ
2014;
23
: 63–67.
41. Demirbag R, Sade LE, Aydin M, Bozkurt A, Acarturk E. The Turkish
registry of heart valve disease.
Turk Kardiyol Dernegi Arsivi
2013;
41
:
1–10.
42. Martins LC, Freire CM, Capurucu CA, Nunes Mdo C, Rezende CA.
Risk prediction of cardiovascular complications in pregnant women
with heart disease.
Arquivos Brasil Cardiol
2016;
106
: 289–296.
43. Nqayana T, Moodley J, Naidoo DP. Cardiac disease in pregnancy.